Department of Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands.
AIDS. 2010 Jan 16;24(2):211-5. doi: 10.1097/QAD.0b013e328334442e.
HLA-B alleles of HIV-infected individuals have been shown to have a major impact on their rate of progression toward AIDS, and the T-cell responses they restrict are immunodominant.
We sought to identify whether the association of HLA-B alleles with rate of progression toward AIDS is due to targeting of more restricted and thus more conserved regions of the HIV-1 proteome.
Each residue of the HIV-1 consensus subtype B sequence was coded according to the presence/absence of an epitope, using the compiled epitope data available in the HIV-LANL immunology database. The Shannon entropy for each HXB2 position was calculated using pre-aligned HIV-1 clade B sequences as a measure of its degree of conservation. We then compared the entropy of empty versus epitope-containing positions and HLA-B-restricted versus HLA-A-restricted positions.
Positions containing CD8 epitopes were significantly more conserved than corresponding empty positions. Moreover, residues targeted by HLA-B alleles in the HIV-1 proteome were significantly more conserved than the ones targeted by HLA-A alleles. Analysing a recent dataset, we found that B epitope regions contain significantly more escape mutations and reversions, which might be the reason why we find them to be more conserved.
Our results suggest that epitopes in HIV-1 targeted by HLA-B alleles lie in more constrained regions of its proteins, in which mutations might have a higher fitness cost and tend to revert. Consequently, HLA-B-restricted cytotoxic T-lymphocyte (CTL) responses may persist longer. This may be one of the factors contributing to the immunodominance and impact of HLA-B-restricted CTL responses on disease progression.
已证实,HIV 感染者的 HLA-B 等位基因对其向艾滋病进展的速度有重大影响,而受其限制的 T 细胞反应具有免疫优势。
我们试图确定 HLA-B 等位基因与向艾滋病进展速度的相关性是否归因于针对 HIV-1 蛋白质组中更受限且因此更保守的区域。
使用 HIV-LANL 免疫学数据库中可用的已编译表位数据,根据表位的存在/缺失对 HIV-1 共识亚型 B 序列的每个残基进行编码。使用预对齐的 HIV-1 分支 B 序列计算每个 HXB2 位置的香农熵,作为其保守程度的度量。然后比较空位与含表位位置以及 HLA-B 限制与 HLA-A 限制位置的熵。
含 CD8 表位的位置明显比相应的空位更保守。此外,HIV-1 蛋白质组中 HLA-B 等位基因靶向的残基明显比 HLA-A 等位基因靶向的残基更保守。分析最近的数据集,我们发现 B 表位区域含有更多的逃逸突变和回复突变,这可能是我们发现它们更保守的原因。
我们的结果表明,HLA-B 等位基因靶向的 HIV-1 表位位于其蛋白质的更受限区域,其中突变可能具有更高的适应度成本并倾向于回复。因此,HLA-B 限制的细胞毒性 T 淋巴细胞(CTL)反应可能持续时间更长。这可能是 HLA-B 限制的 CTL 反应对疾病进展的免疫优势和影响的因素之一。